Overcoming patient barriers to initiating insulin therapy in type 2 diabetes mellitus.

Overcoming patient barriers to initiating insulin therapy in type 2 diabetes mellitus. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Overcoming patient barriers to initiating insulin therapy in type 2 diabetes mellitus. Abstract Text:

David G Marrero,

Data from clinical trials underscore the fact that loss of beta-cell function and insulin hyposecretion are progressive in type 2 diabetes. To achieve adequate glycemic control, most patients will eventually require insulin. Addition of insulin to sulfonylurea therapy, when maximal sulfonylurea does not adequately maintain fasting plasma glucose levels at <108 mg/dL, has been found to be more effective than initiating insulin therapy after oral agents have failed to maintain glycemic control. Nonetheless, both patients and providers are reluctant to begin insulin therapy. Research has shown that providers often delay modification of the diabetes treatment regimen because they believe their patients would be concerned about starting insulin therapy. In addition, they are concerned about patient nonadherence to nonpharmacologic and pharmacologic therapy. There are multiple reasons for patient nonadherence to insulin therapy; however, patients must be made to understand, early in the course of the disease, the progressive nature of type 2 diabetes and that exogenous insulin is an additional therapeutic option to help them achieve and maintain adequate glycemic control.

Overcoming patient barriers to initiating insulin therapy in type 2 diabetes mellitus. Publishing Authors By Initials

DG Marrero,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Overcoming patient barriers to initiating insulin therapy in type 2 diabetes mellitus. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Clinical cornerstone

VOLUME: 8

Page Numbers: 33-40; discussion 41-3

Journal Abbreviation:

ISSN: 1098-3597

DAY: 24

MONTH: 03

YEAR: 2007

Overcoming patient barriers to initiating insulin therapy in type 2 diabetes mellitus. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9816002

Overcoming patient barriers to initiating insulin therapy in type 2 diabetes mellitus. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Overcoming patient barriers to initiating insulin therapy in type 2 diabetes mellitus. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Overcoming patient barriers to initiating insulin therapy in type 2 diabetes mellitus.

AFFILIATION: Division of Endocrinology & Metabolism, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA. dgmarrer@iupui.edu

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Clin Cornerstone

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Overcoming patient barriers to initiating insulin therapy in type 2 diabetes mellitus Related Publications

• Angiotensin II blockade prevents hyperglycemia-induced activation of JAK and STAT proteins in diabetic rat kidney glomeruli.
• Continuing medical education questions.
• Continuing medical education questions.
• Continuing medical education questions.
• Does age at diabetes diagnosis influence long-term physical and behavioral outcomes?
• Early detection of liver cancer: diagnosis and management.
• How do parents perceive their adolescent's diabetes: a qualitative study.
• Liver transplantation for hepatocellular carcinoma: who benefits and who is harmed?
• MR Imaging of hepatocellular carcinoma in the cirrhotic liver: challenges and controversies.
• Modified Charlson Comorbidity Index for predicting survival after liver transplantation.
• Nerve impulses facilitate voltage-sensitive ion channels in surface astrocytes of frog optic nerve.
• Overcoming patient barriers to initiating insulin therapy in type 2 diabetes mellitus.
• Regulation of angiotensin II-induced phosphorylation of STAT3 in vascular smooth muscle cells.
• Resection of a left atrial hemangioma. Report of a case and overview of the literature on resected cardiac hemangiomas.
• Risk factors for hepatocellular carcinoma may impair the performance of biomarkers: a comparison of AFP, DCP, and AFP-L3.
• Translating the Diabetes Prevention Program into the Community The DEPLOY Pilot Study.
• [Carotid angiography; its application in the study of vascular and tumoral diseases of the brain.]
• [Case of cerebellar ganglioglioma; presentation of a case and histologic study of the tumor.]
• [Considerations on the intracranial hypertension syndrome.]
• [Equilibrium disorders in expansive lesions of the supratentorial region.]